CXCL12 promotes human ovarian cancer cell invasion through suppressing ARHGAP10 expression
CXCL12 promotes human ovarian cancer cell invasion through suppressing ARHGAP10 expression
复制标题
CXCL12通过抑制ARHGAP10表达促进人卵巢癌细胞侵袭
DOI:
10.1016/j.bbrc.2019.07.098
复制
发表时间:
2019-10-20
影响因子:
3.1
通讯作者:
Cheng, Zhong-ping
中科院分区:
文献类型:
--
作者:
Luo, Ning;Chen, Dan-dan;Cheng, Zhong-ping
The CXCL12/CXCR4 axis is strongly implicated as key determinant of tumor invasion and metastasis in ovarian cancer. However, little is known about the potential downstream signals of the CXCL12/CXCR4 axis that contribute to ovarian cancer cell invasion and metastasis. ARHGAP10, a member of Rho GTPase activating proteins is a potential tumor suppressor gene in ovarian cancer. In this study, a negative correlation between the protein levels of CXCL12, CXCR4, vascular endothelial growth factor (VEGF), vascular endothelial growth factor receptor-2 (VEGFR2) and ARHGAP10 was uncovered in ovarian cancer tissues and paired adjacent noncancerous tissues. CXCL12 stimulation reduced the expression of ARHGAP10. Furthermore, the pretreatment of CXCR4 inhibitor (AMD3100) or the vascular endothelial growth factor receptor-2 (VEGFR2) inhibitor (SU1498) abrogated the CXCL12-deduced expression of ARHGAP10. Finally, an in vitro functional assay revealed that CXCL12 did not stimulate ovarian cancer cell invasion when ARHGAPIO was overexpressed or when ovarian cancer cells were pre-treated with AMD3100 or SU1498. Knockdown of ARHGAPIO significantly suppressed the inhibitory effects of SU1498 on ovarian cancer cell invasion and lung metastasis. In summary, these findings suggest that CXCL12/CXCR4 promotes ovarian cancer cell invasion by suppressing ARHGAP10 expression, which is mediated by VEGF/VEGFR2 signaling. (C) 2019 Elsevier Inc. All rights reserved.